Expanding access to hereditary cancer genetic testing: a quality improvement initiative of mainstreaming in a diverse urban gynecology clinic - Alex Raghunandan; Lauren Davis-Rivera; Muhammad Danyal Ahsan; Isabelle R. Chandler; Steve Lopez; Amanda Laterza Ozarowski; Michelle Primiano; Christina Pardo; Ravi N. Sharaf; Melissa K. Frey (Familial Cancer, 2026)

When screentime fails: initiative to improve completion of hereditary cancer genetic testing after telemedicine counseling - Isabel R. Murray; Muhammad Danyal Ahsan; Lauren Mitchell; Siena Gioia; Michelle Primiano; Amanda Laterza Ozarowski; Tina Karimaghaie; Steve Lopez; Ravi N. Sharaf; Melissa K. Frey (Familial Cancer, 2026)

Pathogenic CDKN2A germline variants are rare in a cohort of unselected pancreatic cancer patients from Pakistan - Shumaila Arif; Noor Muhammad; Humaira Naeemi; Muhammad Usman Rashid (Familial Cancer, 2025)

Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome? - Ryan Matthew Kahn; Muhammad Danyal Ahsan; Eloise Chapman-Davis; Kevin Holcomb; Roni Nitecki; Jose Alejandro Rauh-Hain; Rana Khan Fowlkes; Francesca Tubito; Maira Pires; Paul J Christos; Kaitlyn Tkachuk; Hannah Krinsky; et al. (Familial Cancer, 2023)

Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan - Muhammad Usman Rashid; Noor Muhammad; Umara Shehzad; Faiz Ali Khan; Asif Loya; Ute Hamann (Familial Cancer, 2023)

Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators - Muhammad Salman Faisal; Carol A. Burke; Jean-Paul Achkar; Benjamin Click; Margaret O’Malley; Lisa LaGuardia; Susan Milicia; Brandie Leach; David Liska; James Church; Matthew Kalady; Gautam Mankaney (Familial Cancer, 2022)

Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome - Shahid Mahmood Baig; Ambrin Fatima; Muhammad Tariq; Tahir Naeem Khan; Zafar Ali; Mohammad Faheem; Humera Mahmood; Patrick Killela; Matthew Waitkus; Yiping He; Fangping Zhao; Sizhen Wang; et al. (Familial Cancer, 2019)

Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population - Syeda Hafiza Benish Ali; Kashif Sardar Bangash; Abdur Rauf; Muhammad Younis; Khursheed Anwar; Raja Khurram; Muhammad Athar Khawaja; Maleeha Azam; Abid Ali Qureshi; Saeed Akhter; Lambertus A. Kiemeney; Raheel Qamar (Familial Cancer, 2017)

Germline mutations predisposing to non-small cell lung cancer - Gerald H. Clamon; Aaron D. Bossler; Taher Abu Hejleh; Muhammad Furqan (Familial Cancer, 2015)

Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients - Muhammad U. Rashid; Sidra Gull; Kashif Asghar; Noor Muhammad; Asim Amin; Ute Hamann (Familial Cancer, 2012)

Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from Pakistan - Muhammad U. Rashid; Sidra Gull; Saima Faisal; Saba Khaliq; Kashif Asghar; Neelam Siddiqui; Asim Amin; Ute Hamann (Familial Cancer, 2011)

Papillary thyroid cancer in a patient with MUTYH-associated polyposis (MAP) - Muhammad Ali Pervaiz; Amanda Eppolito; Karen Schmidt (Familial Cancer, 2010)